News

Published on 6 Oct 2024 on Insider Monkey · via Yahoo Finance

Allogene Therapeutics, Inc. (ALLO): Among the Rising Penny Stocks to Invest In...


Article preview image

We recently compiled a list of the 7 Best Rising Penny Stocks To Invest In Now. In this article, we are going to take a look at where Allogene Therapeutics, Inc. (NASDAQ:ALLO) stands against the other rising penny stocks.

Fed’s Rate Cut Sets the Stage for a Strong Q4

In an episode of Market Storylines on the Inside the Icehouse Podcast feed by Intercontinental Exchange, Jay Woods, Chief Global Strategist at Freedom Capital Markets, discussed Fed rate cuts and the Q4 outlook. Woods discussed the latest Fed rate cut and said that the market absorbed the rate cuts quite positively, with the S&P 500 reaching new all-time highs.

NASDAQ.ALLO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases

The FDA clears ALLO's investigational new drug application to start clinical studies on its...

Zacks · via Yahoo Finance 29 Jan 2025

Allogene Therapeutics Inc (ALLO) Q3 2024 Earnings Call Highlights: Financial...

Allogene Therapeutics Inc (ALLO) reports a strong cash position and promising clinical progress,...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

Allogene Therapeutics Inc (ALLO) Q3 2024: Everything You Need To Know Ahead Of...

Allogene Therapeutics Inc (NASDAQ:ALLO) is set to release its Q3 2024 earnings on Nov 7, 2024. Th...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Allogene Therapeutics, Inc. (ALLO): Among the Rising Penny Stocks to Invest In...

We recently compiled a list of the 7 Best Rising Penny Stocks To Invest In Now. In this article, ...

Insider Monkey · via Yahoo Finance 6 Oct 2024

Allogene Therapeutics, Inc. (ALLO): Short Seller Sentiment is Bearish on This...

We recently compiled a list of the 10 Worst Cancer Stocks To Buy Now According to Short Sellers. ...

Insider Monkey · via Yahoo Finance 19 Sep 2024

With 56% institutional ownership, Allogene Therapeutics, Inc. (NASDAQ:ALLO) is a...

Key Insights Significantly high institutional ownership implies Allogene Therapeutics' stock pric...

Simply Wall St. · via Yahoo Finance 18 Jun 2024

Allogene Therapeutics, Inc. (ALLO): Are Analysts Bullish About the Potential of...

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates

Allogene Therapeutics (ALLO) delivered earnings and revenue surprises of 0% and 47.62%,...

Zacks · via Yahoo Finance 24 Apr 2024

How Allogene (ALLO) Stock Stands Out in a Strong Industry

One stock that might be an intriguing choice for investors right now is Allogene Therapeutics, In...

Zacks via Yahoo Finance 8 Apr 2024

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2023 Earnings Call Transcript March 14, 2024 Allogen...

Insider Monkey via Yahoo Finance 16 Mar 2024